Skip to main content
. 2007 Jan 9;96(3):417–423. doi: 10.1038/sj.bjc.6603494

Table 2. Human adeno and squamous cell carcinoma so far reported to show a significant correlation of EpCAM expression with survival prognosis.

Negative impact on overall survival
 Node-positive breast cancer
 Epithelial ovarian cancer
 Gall bladder cancer
 Cholangiocarcinoma
 Ampullary pancreas cancer
 Squamous cell cancer of esophagus
 Squamous cell head & neck cancer
 
Positive impact on overall survival
 Gastric cancer (stages I and II)
 Clear cell renal cancer
 Moderately differentiated stage II colon cancer
 Non-small-cell lung cancer stage at stage pT2